Effect of cilostazol on vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression in human umbilical vein endothelial cells
Weihong Lu
Abstract
Weihong Lu
Abstract
Objective To investigate the effect of cilostazol on vascular adhesion molecule-1(VCAM-1) and intercellular adhesion molecule-1(ICAM-1) expression in human umbilical vein endothelial cells(HUVECs) and the possible mechanism of the antiatherosclerotic effect. Methods HUVECs were cultivated in vitro,pretreated with cilostazol in different concentrations(0 μg/L,0.05 μg/L,0.1 μg/L,1.0 μg/L,10 μg/L) for one hour,and by stimulation with tumor necrosis facter-alpha(TNF-α)(10 μg/L) for 24 hours.Reverse transcription-polymerase chain reaction(RT-PCR) was performed to detect the expression of VCAM-1 and ICAM-1 on mRNA. Results Expressions of VCAM-1 and ICAM-1 on mRNA which were up-regulated by TNF-α were significantly suppressed by cilostazol in a dose dependent manner,with the increase of cilostazol concentration,expression of ICAM-1 on mRNA dropped gradually,0.239±0.012,0.205±0.012,0.166±0.010 and 0.136±0.008,expressions of VCAM-1 on mRNA also reduced,0.114±0.048,0.093±0.051,0.083±0.045 and 0.068±0.039. Conclusion The inhibition of function of cilostazol in VCAM-1 and ICAM-1 expression induced by TNF-α,demonstrates that cilostazol has the effect of inhibiting the adhesion of blood mononuclear cell to HUVECs,and this contributes to antiatherosclerotic effect of cilostazol on the onset and development of atherosclerosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of cilostazol on vascular adhesion molecule-1(VCAM-1) and intercellular adhesion molecule-1(ICAM-1) expression in human umbilical vein endothelial cells(HUVECs) and the possible mechanism of the antiatherosclerotic effect. Methods HUVECs were cultivated in vitro,pretreated with cilostazol in different concentrations(0 μg/L,0.05 μg/L,0.1 μg/L,1.0 μg/L,10 μg/L) for one hour,and by stimulation with tumor necrosis facter-alpha(TNF-α)(10 μg/L) for 24 hours.Reverse transcription-polymerase chain reaction(RT-PCR) was performed to detect the expression of VCAM-1 and ICAM-1 on mRNA. Results Expressions of VCAM-1 and ICAM-1 on mRNA which were up-regulated by TNF-α were significantly suppressed by cilostazol in a dose dependent manner,with the increase of cilostazol concentration,expression of ICAM-1 on mRNA dropped gradually,0.239±0.012,0.205±0.012,0.166±0.010 and 0.136±0.008,expressions of VCAM-1 on mRNA also reduced,0.114±0.048,0.093±0.051,0.083±0.045 and 0.068±0.039. Conclusion The inhibition of function of cilostazol in VCAM-1 and ICAM-1 expression induced by TNF-α,demonstrates that cilostazol has the effect of inhibiting the adhesion of blood mononuclear cell to HUVECs,and this contributes to antiatherosclerotic effect of cilostazol on the onset and development of atherosclerosis.
Key concepts: Cilostazol, Umbilical vein, Cell adhesion molecule, Medicine, Intercellular Adhesion Molecule-1, Adhesion, Messenger RNA, Peripheral blood mononuclear cell